I agree, in the absence of any post-marketing safety issues, it makes sense that this will be the delivery approach for these drugs in the future.
As I was saying before, the economic opportunity will be linked to the granting and defensibility of patents. Otherwise will be a very competitive, low margin business.
I agree, in the absence of any post-marketing safety issues, it...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
-0.010(3.39%) |
Mkt cap ! $33.02M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 31.0¢ | 28.5¢ | $50.18K | 173.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 46799 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 3455 | 2 |
View Market Depth
| Last trade - 10.37am 23/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |